Four different materials (two ab initio synthesized polyurethanes; ready-to-use: Epon1002F and poly(vinyl alcohol)/N-methyl-4(4'-formylstyryl)pyridinium methosulfate acetal) for the generation of Escherichia coli surface imprints are compared in this work. The use of commercially available, ready-to-use materials instead of self-synthesized polymers represents an innovative and convenient way of molecular imprint fabrication. This was herein investigated for large, biological templates. Fully synthesized imprint materials (polyurethanes) were developed and optimized regarding their OH excess and the use of catalyst in the polymerization reaction. No to low OH excess (0-10%) and a noncatalyzed synthesis were determined to be superior for the imprinting of the Gram-negative bacteria. Imprints were characterized using atomic force microscopy, with Epon1002F yielding the most distinguished imprints, along with a smooth surface. The imprints were afterward tested as plastic antibody coatings in a mass-sensitive quartz-crystal microbalance measurement. Dilutions of E. coli suspensions, down to a limit of detection of 1.4 × 10 CFU/mL, were successfully measured. Best results were obtained with Epon1002F and self-synthesized, stoichiometric polyurethane. Since ready-to-use Epon1002F was superior in terms of signal intensities and sensitivity, it can advantageously replace self-synthesized polymers for the generation of imprinted sensor surfaces. Easy day-to-day reproducibility and further shortening of imprint fabrication time are other advantages of employing the ready-to-use material instead of conventionally synthesized polymers.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.